This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 104 pages and 3 tables